Nanomaterials and Its Potential in Health Concern Treatment
A special issue of Pharmaceutics (ISSN 1999-4923). This special issue belongs to the section "Nanomedicine and Nanotechnology".
Deadline for manuscript submissions: 10 August 2024 | Viewed by 4127
Special Issue Editors
Interests: nanotechnology; nanomaterials; bionanomaterials; drug delivery nanoparticles; biopolymers; macromolecules; antibacterial
Interests: materials science; biochemistry; chemistry; medicine; biological sciences; pharmacology; immunology and microbiology
Interests: nanoscience; nanotechnology; materials science and technology; biochemistry; chemistry; medicine; biological sciences; pharmacology; drug delivery
Special Issues, Collections and Topics in MDPI journals
Interests: nanoscience; nanotechnology; microfluidics; materials science and technology; colloids; chemistry; biological Sciences; pharmacology; protein; immunology
Special Issue Information
Dear Colleagues,
Nanomaterials are on the border of biomedicine since they bring a plethora of novel and potential treatments for a given disease. The nanomaterials consist of a support matrix, organic or inorganic in nature, able to load, entrap, transport, and deliver bioactive compounds of low molecular weight. The design and engineering of nanomaterials result from the intercorrelation of chemistry, physics, biology, science, and technology of material, among other disciplines. Nanomaterials have been proposed, thanks to their unique and intrinsic physicochemical properties, as diagnostic, therapeutic, and/or theragnostic agents to face front to health concern problems that afflict the world population.
In this regard, the present Special Issue aims to invite authors to submit papers or reviews to provide actual information on the current progress in nanomaterials development and their potential in health concerns treatment.
Dr. Josué Juárez
Dr. Marco A. López-Mata
Dr. Natalia Hassan
Dr. Antonio Topete Camacho
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceutics is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nanomaterials
- engineering nanomaterials
- biomaterials
- material science
- functional nanomaterials
- composite nanomaterials
- hybrid nanomaterials
- biological sciences
- microbiology
- antibacterial agents